Literature DB >> 1182657

Eccrine sweat gland tumor of clear cell origin involving the eyelids.

Y Rosen, B Kim, V A Yermakov.   

Abstract

A 47-year-old patient with an unusual tumor involving the right upper and lower eyelids has been followed for almost 6 years. The tumor has remained localized to the eyelids and has recurred locally following attempts at complete or partial excision. The morphological features of the tumor as seen by ordinary light microscopic methods were puzzling, and resulted in a variety of pathologic diagnoses. Light microscopic examination of plastic-embedded semithin sections, and electron microscopic examination indicate that this is a hitherto undescribed eccrine sweat gland tumor of clear cell origin. Its infiltrative growth pattern and tendency to local recurrence suggests that it may be a low-grade malignant neoplasm.

Entities:  

Mesh:

Year:  1975        PMID: 1182657     DOI: 10.1002/1097-0142(197509)36:3<1034::aid-cncr2820360329>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Primary signet ring cell carcinoma of the eyelid in a young woman.

Authors:  R Khoramnia; C Mayer; E Glaser; G Weirich
Journal:  Eye (Lond)       Date:  2011-07-08       Impact factor: 3.775

2.  Aggressive syringomatous carcinoma of the orbit.

Authors:  Shingo Hasegawa; Eiji Kohmura; Akihiro Ichinose; Shinya Tahara; Atsushi Azumi; Chiho Ohbayashi; Ken-ichi Nibu
Journal:  Skull Base       Date:  2005-11

3.  A brief review of different types of sweat-gland carcinomas in the eyelid and orbit.

Authors:  Leilei Zhang; Shengfang Ge; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2013-04-09       Impact factor: 4.147

4.  Diagnostic and treatment challenges of a case of primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.

Authors:  Mathew M Palakkamanil; Muhammad N Mahmood; Audrey Chan
Journal:  BMC Ophthalmol       Date:  2020-10-14       Impact factor: 2.209

5.  Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in CDH1 and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.

Authors:  Lei-Chi Wang; Tai-Chi Lin; Yi-Chen Yeh; Hsiang-Ling Ho; Chieh-Chih Tsai; Teh-Ying Chou
Journal:  Curr Oncol       Date:  2021-02-16       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.